Systemic Treatments and Long-Term Quality of Life

When topical treatments like baths and moisturizers are not enough to manage the thick scaling and pain of epidermolytic ichthyosis (EI), your medical team may discuss systemic (internal) therapies. These medications work from the inside out to change how your skin grows, but they require a high level of commitment and careful monitoring.

Oral Retinoids: Managing the Growth Cycle

The most common systemic treatments for severe EI are oral retinoids, such as acitretin ^[1]. These are synthetic forms of Vitamin A that help regulate how quickly skin cells are produced and shed, which can significantly reduce the thickness of hyperkeratotic scales ^[2]. These are specialist-directed and often used off-label, with patient responses varying widely.

Important Monitoring and Safety

Because oral retinoids affect systems throughout the body, your doctor will require regular check-ups and blood tests:

• Adverse Effects: Common mucocutaneous effects include dry lips, dry eyes, and peeling skin. Retinoids can sometimes even worsen skin fragility or blistering, requiring careful dose adjustment. Never alter or stop therapy without consulting your prescriber.
• Organ Function: You will need regular baseline and periodic blood work to monitor your liver enzymes and lipids (cholesterol and triglycerides), as these can sometimes become elevated during treatment ^[3]. They may be contraindicated if you have liver disease or significant hyperlipidemia.
• Bone and Growth Monitoring: In children, long-term use of retinoids requires monitoring of bone growth and skeletal health, as these medications can occasionally affect the growth plates ^[1].
• Pregnancy Precautions: This is the most critical safety issue for acitretin. It is highly teratogenic and can cause severe birth defects if taken during pregnancy. Because the medication stays in the body’s fat cells for a long time, patients who can become pregnant must use strict, highly effective contraception, undergo regular pregnancy testing during treatment, and avoid pregnancy for an extended period—often up to three years after stopping the medication, depending on local regulatory requirements ^[4].
• Alcohol Restriction: Alcohol must be strictly avoided during treatment and for the required post-treatment interval. Alcohol allows acitretin to convert into etretinate, which is highly persistent, prolonging the danger to a fetus. Blood donation is also heavily restricted.

The Emerging Role of Biologics

Researchers are currently investigating biologics—targeted medications that block specific parts of the immune system—to see if they can help with the inflammation and scaling in EI.

• Mixed Results: In a small trial of adults with various types of ichthyosis, a biologic called secukinumab (which targets a protein called IL-17A) did not show a significant overall reduction in disease severity after 16 weeks ^[5].
• Pediatric Reports: Interestingly, some individual case reports of children with EI have shown much better results, with significant improvements in skin redness and scaling after using biologics ^[6][7].
• The Verdict: Biologics are currently experimental and not the standard treatment for EI. They are usually only considered “off-label” for severe cases that haven’t responded to other therapies ^[5][8].

Managing the Daily Burden and Quality of Life

Living with EI is about more than just managing the appearance of the skin; it is about managing the sensory and emotional weight of the condition.

• Pain and Itch: In an observational cohort study of 48 people, approximately half of those with EI experience chronic, severe pain and persistent itching ^[9]. These symptoms are often linked to deep cracks (fissures) or the inflammation caused by the broken skin barrier ^[10].
• Daily Life Restrictions: The same study of 48 people with EI found that 78% reported their daily life was restricted by the time and effort required for their skin care ^[9]. This “treatment burden” can lead to stress, feelings of inferiority, and a sense of isolation ^[10].
• Financial Strain: For about one-quarter of patients, the cost of the large amounts of moisturizers and ointments needed is not fully covered by insurance, adding financial stress to the physical burden of care ^[9].

Support and Advocacy

Because the psychosocial impact of EI is so high, it is important to treat your mental health with the same priority as your skin. This may include:

• Connecting with patient advocacy groups to share experiences and care tips.
• Working with a social worker to navigate insurance coverage for necessary topicals ^[9].
• Discussing “treatment fatigue” openly with your doctor to see if your routine can be simplified without sacrificing skin health.